Avicanna Announces Sponsorship of University of Calgary THC Dose Finding Clinical Trial
New randomized controlled trial to evaluate dose-dependent effects of oral THC on anxiety and stress using Avicanna’s proprietary capsules New randomized controlled trial to evaluate dose-dependent effects of oral THC on anxiety and stress using Avicanna’s pr…
TORONTO, March 16, 2026 (GLOBE NEWSWIRE) — Avicanna Inc. (Avicanna or the Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and c…